Lindbrook Capital, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,500
+22.0%
2,5000.0%0.00%0.0%
Q2 2023$6,150
+8.8%
2,5000.0%0.00%0.0%
Q1 2023$5,650
-35.2%
2,5000.0%0.00%0.0%
Q4 2022$8,725
-90.9%
2,500
-3.7%
0.00%
-93.8%
Q3 2022$96,000
+100.0%
2,596
+2.9%
0.02%
+100.0%
Q2 2022$48,000
-28.4%
2,523
+0.9%
0.01%
-20.0%
Q1 2022$67,000
+19.6%
2,5000.0%0.01%
+11.1%
Q4 2021$56,0002,5000.01%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders